HK1034899A1 - Use of tetracyclines for treating meibomian gland disease - Google Patents

Use of tetracyclines for treating meibomian gland disease

Info

Publication number
HK1034899A1
HK1034899A1 HK01105481A HK01105481A HK1034899A1 HK 1034899 A1 HK1034899 A1 HK 1034899A1 HK 01105481 A HK01105481 A HK 01105481A HK 01105481 A HK01105481 A HK 01105481A HK 1034899 A1 HK1034899 A1 HK 1034899A1
Authority
HK
Hong Kong
Prior art keywords
meibomian gland
gland disease
tetracyclines
treating
tetracycline
Prior art date
Application number
HK01105481A
Other languages
English (en)
Inventor
Stephen C Pflugfelder
Balakrishna L Lokeshwar
Marie Selzer
Original Assignee
Univ Miami
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Miami filed Critical Univ Miami
Publication of HK1034899A1 publication Critical patent/HK1034899A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK01105481A 1998-05-08 2001-08-07 Use of tetracyclines for treating meibomian gland disease HK1034899A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8487398P 1998-05-08 1998-05-08
PCT/US1999/009965 WO1999058131A1 (en) 1998-05-08 1999-05-07 Use of tetracyclines for treating meibomian gland disease

Publications (1)

Publication Number Publication Date
HK1034899A1 true HK1034899A1 (en) 2001-11-09

Family

ID=22187748

Family Applications (2)

Application Number Title Priority Date Filing Date
HK01105481A HK1034899A1 (en) 1998-05-08 2001-08-07 Use of tetracyclines for treating meibomian gland disease
HK06111578.1A HK1089696A1 (en) 1998-05-08 2006-10-20 Use of sub-antimicrobial tetracyclines for treating ocular rosacea

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK06111578.1A HK1089696A1 (en) 1998-05-08 2006-10-20 Use of sub-antimicrobial tetracyclines for treating ocular rosacea

Country Status (13)

Country Link
US (6) US6455583B1 (xx)
EP (2) EP1676579B1 (xx)
JP (1) JP4860038B2 (xx)
AT (2) ATE319456T1 (xx)
AU (1) AU763164B2 (xx)
CA (1) CA2331257C (xx)
DE (2) DE69930252T2 (xx)
DK (2) DK1075265T3 (xx)
ES (2) ES2320579T3 (xx)
HK (2) HK1034899A1 (xx)
PT (2) PT1676579E (xx)
TW (2) TWI255713B (xx)
WO (1) WO1999058131A1 (xx)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999058131A1 (en) * 1998-05-08 1999-11-18 University Of Miami Use of tetracyclines for treating meibomian gland disease
US6432934B1 (en) * 1998-08-06 2002-08-13 Advanced Vision Research Methods and compositions for topical treatment of eye surface inflammation and related dry eye disease
US6506740B1 (en) * 1998-11-18 2003-01-14 Robert A. Ashley 4-dedimethylaminotetracycline derivatives
AU4684000A (en) * 1999-04-27 2000-11-10 Antibody Systems, Inc. Compositions containing tetracyclines for treating hemorrhagic virus infections and other disorders
CA2447008A1 (en) * 2001-04-05 2002-10-24 Collagenex Pharmaceuticals, Inc. Controlled delivery of tetracycline compounds and tetracycline derivatives
US7211267B2 (en) 2001-04-05 2007-05-01 Collagenex Pharmaceuticals, Inc. Methods of treating acne
EP2301550A1 (en) * 2001-07-13 2011-03-30 Paratek Pharmaceuticals, Inc. Tetracycline compounds having target therapeutic activities
US20030073068A1 (en) * 2001-10-15 2003-04-17 Campbell Robert Edward Methods for application of tear-based biomarkers to ophthalmic product evaluation and clinical study management
US8192749B2 (en) * 2003-04-16 2012-06-05 Galderma Laboratories Inc. Methods of simultaneously treating ocular rosacea and acne rosacea
US7008631B2 (en) * 2002-04-16 2006-03-07 Collagenex Pharmaceuticals, Inc. Methods of simultaneously treating ocular rosacea and acne rosacea
WO2003092629A2 (en) * 2002-05-06 2003-11-13 Collagenex Pharmaceuticals, Inc. Methods of simultaneously treating mucositis and fungal infection
CN103127033A (zh) * 2003-01-22 2013-06-05 千寿制药株式会社 眼疾治疗用经皮吸收型制剂、其使用及眼疾治疗药向眼局部组织的转移方法
EP2204168B1 (en) * 2003-04-07 2015-01-14 Supernus Pharmaceuticals, Inc. Once daily formulations of tetracyclines
US6984628B2 (en) * 2003-07-15 2006-01-10 Allergan, Inc. Ophthalmic compositions comprising trefoil factor family peptides
US7485319B2 (en) * 2003-07-25 2009-02-03 Warner Chilcott Company, Inc. Doxycycline metal complex in a solid dosage form
WO2007024972A2 (en) * 2005-08-22 2007-03-01 Quick-Med Technologies, Inc. Non-leaching absorbent wound dressing
CN100340241C (zh) * 2004-06-28 2007-10-03 中山大学中山眼科中心 一种滴眼液及其制备方法与用途
JP5235416B2 (ja) * 2005-01-21 2013-07-10 ワーナー・チルコット・カンパニー・エルエルシー 固体投与形中のテトラサイクリン金属錯体
US7541347B2 (en) * 2007-04-02 2009-06-02 Medicis Pharmaceutical Coropration Minocycline oral dosage forms for the treatment of acne
US20080241235A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080242642A1 (en) 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US7544373B2 (en) 2007-04-02 2009-06-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7981095B2 (en) * 2005-07-18 2011-07-19 Tearscience, Inc. Methods for treating meibomian gland dysfunction employing fluid jet
US20080114423A1 (en) * 2006-05-15 2008-05-15 Grenon Stephen M Apparatus for inner eyelid treatment of meibomian gland dysfunction
US20070060988A1 (en) 2005-07-18 2007-03-15 Grenon Stephen M Melting meibomian gland obstructions
US20090043365A1 (en) 2005-07-18 2009-02-12 Kolis Scientific, Inc. Methods, apparatuses, and systems for reducing intraocular pressure as a means of preventing or treating open-angle glaucoma
US8255039B2 (en) * 2006-09-29 2012-08-28 Tearscience, Inc. Meibomian gland illuminating and imaging
WO2013003594A2 (en) 2011-06-28 2013-01-03 Tearscience, Inc. Methods and systems for treating meibomian gland dysfunction using radio-frequency energy
US8950405B2 (en) * 2006-05-15 2015-02-10 Tearscience, Inc. Treatment of obstructive disorders of the eye or eyelid
US7981145B2 (en) 2005-07-18 2011-07-19 Tearscience Inc. Treatment of meibomian glands
US7981146B2 (en) 2006-05-15 2011-07-19 Tearscience Inc. Inner eyelid treatment for treating meibomian gland dysfunction
US8083787B2 (en) 2005-07-18 2011-12-27 Tearscience, Inc. Method and apparatus for treating meibomian gland dysfunction
US8137390B2 (en) * 2006-05-15 2012-03-20 Tearscience, Inc. System for providing heat treatment and heat loss reduction for treating meibomian gland dysfunction
US8128674B2 (en) 2006-05-15 2012-03-06 Tearscience, Inc. System for outer eyelid heat and pressure treatment for treating meibomian gland dysfunction
US7981147B2 (en) 2006-05-15 2011-07-19 Tearscience, Inc. Outer eyelid heat and pressure treatment for treating meibomian gland dysfunction
US9314369B2 (en) 2006-05-15 2016-04-19 Tearscience, Inc. System for inner eyelid treatment of meibomian gland dysfunction
US8007524B2 (en) 2006-05-15 2011-08-30 Tearscience, Inc. Heat treatment and heat loss reduction for treating meibomian gland dysfunction
US7976573B2 (en) 2006-05-15 2011-07-12 Tearscience, Inc. Inner eyelid heat and pressure treatment for treating meibomian gland dysfunction
US8128673B2 (en) 2006-05-15 2012-03-06 Tearscience, Inc. System for inner eyelid heat and pressure treatment for treating meibomian gland dysfunction
EP2056753B1 (en) 2006-08-21 2016-06-15 Tearscience, Inc. Apparatus for treating gland dysfunction
WO2008027069A1 (en) * 2006-08-21 2008-03-06 Tearscience, Inc. Method and apparatus for treating meibomian gland dysfunction employing fluid
US8249695B2 (en) 2006-09-29 2012-08-21 Tearscience, Inc. Meibomian gland imaging
EP3434313A1 (en) 2007-01-17 2019-01-30 Tearscience, Inc. Methods, systems, and apparatus for heat treatment for treating meibomian gland dysfunction
US20080188445A1 (en) * 2007-02-02 2008-08-07 Warner Chilcott Company Inc. Tetracycline compositions for topical administration
US20080188446A1 (en) * 2007-02-02 2008-08-07 Warner Chilcott Company Inc. Tetracycline compositions for topical administration
CN101668511A (zh) * 2007-02-28 2010-03-10 阿西克斯医疗公司 正常化睑板腺分泌的方法和化合物
US20080241197A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline dosage forms for the treatment of acne
JP5894364B2 (ja) * 2007-08-16 2016-03-30 ザ スキーペンズ アイ リサーチ インスティチュート インコーポレイテッド 眼および付属器組織の炎症を処置するための治療組成物
US20090131303A1 (en) * 2007-11-16 2009-05-21 Bor-Shyue Hong Methods and compositions for treating dry eye
USD617443S1 (en) 2008-02-06 2010-06-08 Tearscience, Inc. Eye treatment goggles
USD613408S1 (en) 2008-02-06 2010-04-06 Tearscience, Inc. Eye treatment head gear
CA2719453A1 (en) * 2008-03-26 2009-10-01 Eric Donnenfeld Methods for improving lid margin and tear film function and treatment of lid margin disease using tetracycline family antibiotics
WO2010006306A1 (en) * 2008-07-10 2010-01-14 Inspire Pharmaceuticals, Inc. Method of treating blepharitis
WO2010017310A1 (en) 2008-08-06 2010-02-11 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
WO2010085572A1 (en) * 2009-01-23 2010-07-29 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with azithromycin
JP5658228B2 (ja) 2009-04-01 2015-01-21 テイアサイエンス・インコーポレーテツド 眼球涙液膜の画像形成、処理および／または表示を行いおよび／または眼球涙液膜層の厚さを測定する、眼球表面の干渉分光（ｏｓｉ）装置、システムおよび方法
USD638128S1 (en) 2009-10-06 2011-05-17 Tearscience, Inc. Ocular device design
US8721572B1 (en) 2010-06-10 2014-05-13 Eyedetec Medical, Inc. Systems, devices, kits and methods for therapy of the eye
US20120190653A1 (en) * 2011-01-20 2012-07-26 Dow Pharmaceutical Sciences, Inc. Therapeutic eye drop comprising doxycycline and a stabilizer
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
US9636355B2 (en) 2011-09-22 2017-05-02 Theo Holdings, Llc Hypertonic dextran solution and methods of treating and preventing recurrent corneal erosion
UA109359C2 (xx) * 2011-11-10 2015-08-10 Лікування захворювань і станів шкіри 7-(1h-імідазол-4-ілметил)-5,6,7,8-тетрагідрохіноліном
US9931031B2 (en) 2012-02-21 2018-04-03 Massachusetts Eye & Ear Infirmary Meibomian gland dysfunction
US9110030B2 (en) 2012-06-29 2015-08-18 Daniel A. Kerschensteiner Colorimetric gelatinase assay
US10842670B2 (en) 2012-08-22 2020-11-24 Johnson & Johnson Vision Care, Inc. Apparatuses and methods for diagnosing and/or treating lipid transport deficiency in ocular tear films, and related components and devices
PT106679B (pt) * 2012-11-27 2015-03-25 Hovione Farmaciencia Sa Formulações tópicas de tetraciclinas, sua preparação e usos
US10092449B2 (en) 2013-04-30 2018-10-09 Tear Film Innovations, Inc. Systems and methods for the treatment of eye conditions
US9763827B2 (en) 2013-04-30 2017-09-19 Tear Film Innovations, Inc. Systems and methods for the treatment of eye conditions
US10278587B2 (en) 2013-05-03 2019-05-07 Tearscience, Inc. Eyelid illumination systems and method for imaging meibomian glands for meibomian gland analysis
US10130507B2 (en) 2013-08-03 2018-11-20 Michael C. Whitehurst Dry eye treatment device
US20170232024A1 (en) * 2014-08-04 2017-08-17 Jerry Tan Eye Surgery Pte Ltd Pharmaceutical compositions for demodex related blepharitis and eyelid crusting
US9532996B2 (en) 2014-11-19 2017-01-03 Dr. Reddy's Laboratories Ltd. Modified release doxycycline composition
JP6793715B2 (ja) 2015-03-23 2020-12-02 バイオファーミクス・インコーポレイテッドＢｉｏＰｈａｒｍＸ， Ｉｎｃ． テトラサイクリンの皮膚用医薬組成物
EP3178462A1 (de) 2015-12-07 2017-06-14 WDT-Wolz-Dental-Technik GmbH Verfahren zur herstellung eines polychrom und/oder räumlich polychrom oder eines monochrom gefärbten keramischen körpers und vorrichtung hierfür
US10974063B2 (en) 2016-06-30 2021-04-13 Alcon Inc. Light therapy for eyelash growth
US10667951B2 (en) 2016-08-29 2020-06-02 Nicole Kyongnan Renaud Eye mask
FR3064482B1 (fr) * 2017-04-03 2020-11-13 Horus Pharma Composition topique de doxycycline
KR20200111177A (ko) 2017-12-15 2020-09-28 타르서스 파마수티칼스, 아이엔씨. 안검염을 치료하기 위한 이속사졸린 구충제 제제 및 방법
WO2024008951A1 (en) * 2022-07-08 2024-01-11 Icm (Institut Du Cerveau Et De La Moelle Épinière) Tetracycline derivatives

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE788479A (fr) * 1971-09-06 1973-01-02 Medimpex Gyogyszerkulkereskede Complexes du tris(hydroxymethyl)aminomethane avec les tetracyclines formant des solutions neutres, stables, tres actives etnon toxiques
CA1263606A (en) * 1985-05-29 1989-12-05 Jeffrey P. Gilbard Non-toxic opthalmic preparations
IE74244B1 (en) * 1985-10-01 1997-07-16 Bimeda Res Dev Ltd A process for preparing an antibiotic composition
US4866049A (en) * 1987-08-10 1989-09-12 Spectra Pharmaceutical Services, Inc. Ophthalmic compositionn and method of using same
US5360611A (en) * 1988-10-03 1994-11-01 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following ultraviolet laser irradiation
FR2660193B1 (fr) * 1990-04-03 1994-11-04 Philippe Maincent Produit opthalmique comportant des nanocapsules, son procede de preparation et utilisation des nanocapsules.
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
US5523297A (en) * 1993-03-02 1996-06-04 The Research Foundation Of State University Of New York Inhibition of excessive phospholipase A2 activity and/or production by non-antimicrobial tetracyclines
US5422116A (en) * 1994-02-18 1995-06-06 Ciba-Geigy Corporation Liquid ophthalmic sustained release delivery system
US5789395A (en) * 1996-08-30 1998-08-04 The Research Foundation Of State University Of New York Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
US6015803A (en) * 1998-05-04 2000-01-18 Wirostko; Emil Antibiotic treatment of age-related macular degeneration
WO1999058131A1 (en) * 1998-05-08 1999-11-18 University Of Miami Use of tetracyclines for treating meibomian gland disease
US6432934B1 (en) * 1998-08-06 2002-08-13 Advanced Vision Research Methods and compositions for topical treatment of eye surface inflammation and related dry eye disease

Also Published As

Publication number Publication date
US6455583B1 (en) 2002-09-24
TW200526232A (en) 2005-08-16
US20120088739A1 (en) 2012-04-12
EP1075265A1 (en) 2001-02-14
US20060154901A1 (en) 2006-07-13
US20110039805A1 (en) 2011-02-17
DK1075265T3 (da) 2006-06-26
ES2320579T3 (es) 2009-05-25
WO1999058131A1 (en) 1999-11-18
TWI255713B (en) 2006-06-01
US20030114426A1 (en) 2003-06-19
CA2331257A1 (en) 1999-11-18
US20080214510A1 (en) 2008-09-04
AU3887999A (en) 1999-11-29
EP1676579B1 (en) 2008-12-31
ATE418989T1 (de) 2009-01-15
AU763164B2 (en) 2003-07-17
DE69930252D1 (de) 2006-05-04
EP1676579A3 (en) 2006-07-12
ATE319456T1 (de) 2006-03-15
ES2260912T3 (es) 2006-11-01
CA2331257C (en) 2012-01-03
JP2002514602A (ja) 2002-05-21
PT1075265E (pt) 2006-07-31
DK1676579T3 (da) 2009-03-16
DE69940227D1 (de) 2009-02-12
TWI255714B (en) 2006-06-01
PT1676579E (pt) 2009-03-24
EP1075265B1 (en) 2006-03-08
HK1089696A1 (en) 2006-12-08
JP4860038B2 (ja) 2012-01-25
DE69930252T2 (de) 2006-12-14
EP1676579A2 (en) 2006-07-05

Similar Documents

Publication Publication Date Title
HK1034899A1 (en) Use of tetracyclines for treating meibomian gland disease
EP1225168B8 (en) Prostaglandin-F-2 alpha derivative for the treatment of glaucoma or ocular hypertension
EP0639563A3 (en) Use of cloprostenol, fluprostenol and its analogs for the manufacture of a medicament for the treatment of glaucoma and ocular hypertension.
AU3632497A (en) Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
MX9702349A (es) Usos de derivado de 9-deoxi prostaglandina para tratar glaucoma.
ZA9610508B (en) Pharmaceutical composition comprising l-carnitine or alkanoyl l-carnitine for the prevention and treatment of diseases brought about by lipid metabolism disorders
EP1020179A4 (en) PEPTIDE DERIVATIVES OR THEIR PHARMACEUTICAL ACCEPTABLE SALTS, METHOD FOR THE PRODUCTION THEREOF, USE OF THESE DERIVATIVES AND MEDICINAL PRODUCTS
NO972980D0 (no) Anvendelse av nebivolol som et anti-aterogent middel
GB9103764D0 (en) Compositions
HUP0001097A2 (hu) COMT-inhibitorok alkalmazása cukorbetegséggel kapcsolatos érrendszeri rendellenességek megelőzésére alkalmas gyógyszerkészítmények előállítására
EP0454429A3 (en) Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases
DE69620573D1 (de) Mittel zur verminderung des augeninnendrucks
ATE289817T1 (de) Arzneimittelzusammenstellung zur behandlung des erhöhten augeninnendrucks oder des glaukom
HUP0004647A2 (hu) Glükóz-amino-glükánok alkalmazása diabétesszel társult szembetegségek kezelésére szolgáló gyógyszerkészítmények előállítására
NO961496L (no) Behandling av allergiske sykdommer med terfenadinkarboksylat
MX9706188A (es) Inhibicion de la angiogenesis usando interleucina 12.
HUP9903936A2 (hu) Tiazolidinonszármazék alkalmazása neurodegenerációs rendellenességek kezelésére és megelőzésére szolgáló gyógyszerkészítmények előállítására
UA43800A (uk) Спосіб лікування перфоративної виразки дванадцятипалої кишки

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120507